XENE
US EQUITY
Health Care
Health Care
CIK: 1582313
Xenon Pharmaceuticals Inc. (XENE) Quant Factor Diagnostic & Fair Value Model
Xenon Pharmaceuticals Inc. (Ticker: XENE) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$35.34
-3.18%
Latest Close (2026-10-23)
Market Cap: $3.53B
P/E Ratio: -
Momentum Strength
3M / 12M
-46.28%
1M: -7.15%
12M: 0.00%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
39.2
SMA50: $47.88
SMA200: $54.54
Valuation Multiplier
Trailing
-
Pre-Profit / Negative TTM
📊
Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM
XENE has negative or near-zero trailing GAAP earnings over the trailing twelve months.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 0/9 (Under Pressure or Early Stage Growth)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1582313 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1582313 | ||||||
💡 Methodology & Frequently Asked Questions
Key reference details regarding Xenon Pharmaceuticals Inc. (XENE) valuation multiples, momentum factors, and point-in-time filing conventions.
How should XENE's current valuation multiple be interpreted? ↓
XENE trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are XENE's key momentum and technical factor indicators? ↓
As of the latest close, XENE shows a 1-month return of -7.15%, 3-month return of -46.28%, and 12-month return of 0.00%, with a 14-day RSI of 39.2. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for XENE? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can XENE be incorporated into systematic factor models? ↓
XENE can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.